The Institute for Innovation in Imaging (i3) collaborates with researchers and industry partners to accelerate translation of new tools that detect disease early and monitor emergent treatments. Since 2014, we have obtained 25 patents

The i3 is headquartered at the Massachusetts General Hospital’s Research Campus in the Charlestown Navy Yard. Additional affiliated imaging laboratories are located on the MGH Main Campus in downtown Boston. Please Contact Us with any …

The i3 is headquartered at the Massachusetts General Hospital’s Research Campus in the Charlestown Navy Yard. Additional affiliated imaging laboratories are located on the MGH Main Campus in downtown Boston.

The Institute for Innovation in Imaging (i3) core provides guidance and access to unique resources that enable translation of promising imaging technology or innovative imaging experiments. MISSION. 1) Enable translation of promising imaging technologies.

i3 was created in collaboration with the Massachusetts General Hospital/Harvard Medical School (MGH) and the Technical University of Munich (TUM) to commercialize novel Cardiovascular Imaging Technologies.

Peter Caravan, PhD, is co-director of the Institute for Innovation in Imaging (I 3) at Massachusetts General Hospital and Professor of Radiology at Harvard Medical School. He leads a multidisciplinary and translational molecular imaging lab focused on the invention of novel molecular probes and their broad applications in cardiovascular ...

Our researchers have led multiple novel imaging and therapy approaches and are intimately integrated in the extensive research programs throughout MGH and within the Department of Radiology, including at the MGH Center for Precision Imaging, MGH/Martinos Center, i3 Center, and Center for Systems Biology.

From state-of-the-art laboratories to novel diagnostic probes, high-tech devices, unique animal models, and first in human trials – we can help connect you with your next big step, and support you through the process. At the i3, we understand that no two successes look the same. Contact us to find out how we can help.

Combining standalone intravascular ultrasound imaging (IVUS, clinical standard) with near-infrared fluorescence (NIRF) to look beyond vascular anatomy. NIRF imaging can detect important pathobiological markers of atherosclerosis, like inflammation, which are not visible on standalone IVUS.

Peter Caravan Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging (i3), MGH, Harvard Verified email at mgh.harvard.edu